The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
Journal Article
The Antibacterial Resistance Leadership Group (ARLG), with funding from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, was created in June 2013. Its mission is to develop, prioritize, and implement a clinical research agenda that addresses the public health threat of antibacterial resistance. This article reports on the progress that the ARLG has made to date in fulfilling its mission. Since inception, the ARLG has received and reviewed >70 study proposals, initiated >30 studies, executed >300 agreements, included data from >7000 subjects, published >45 manuscripts, and provided opportunities for 26 mentees. Despite this substantial progress, there remains significant work to be accomplished. This article also describes the considerable challenges that lie ahead.
Full Text
Duke Authors
Cited Authors
- Chambers, HFC; Cross, HR; Evans, SR; Kreiswirth, BN; Fowler, VG; Antibacterial Resistance Leadership Group (ARLG),
Published Date
- March 15, 2017
Published In
- Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Volume / Issue
- 64 / suppl_1
Start / End Page
- S3 - S7
PubMed ID
- 28350896
Pubmed Central ID
- 28350896
Electronic International Standard Serial Number (EISSN)
- 1537-6591
Digital Object Identifier (DOI)
- 10.1093/cid/ciw824
Language
- eng
Conference Location
- United States